Telomerase as a diagnostic and therapeutic target for cancer.
Telomerase is a ribonucleoprotein enzyme responsible for the elongation of telomeres at the ends of chromosomes. It is widely expressed in most cancers, while absent from most normal somatic cells. Telomerase is partially responsible for the cellular immortalization that allows human cancers to progress indefinitely. Due to its widespread occurrence in cancer and its crucial role in the maintenance of the tumor, telomerase is an attractive target for cancer diagnosis and treatment.
Greenebaum Cancer Center, 22 South Greene Street, Baltimore, MD 21201, USA. adoyle@umm.edu
L Austin
LA
Doyle
W Edward
WE
Highsmith
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D016503:Drug Delivery Systems / Q000379:methods*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000201:enzymology*; D019098:Telomerase / Q000032:analysis* / Q000037:antagonists & inhibitors* / Q000096:biosynthesis
D014408:Biomarkers, Tumor; D004791:Enzyme Inhibitors; D019098:Telomerase